STTKShattuck Labs, Inc.

$284M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+12.7% YoY

Gross Profit

-$5M-173.4% margin

Operating Income

-$7M-227.2% margin

Net Income

-$7M-220.2% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+5.5%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$174,000

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

$15M

Cash & Equivalents

-$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+12.7%
Gross Profit	-$5M	-$4M	-43.0%
Operating Income	-$7M	-$5M	-36.4%
Net Income	-$7M	-$5M	-40.4%

STTK Q1 2020 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena